Cambridge Investment Research Advisors, Inc. Charles River Laboratories International, Inc. Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.4 Billion
- Q3 2024
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 1,978 shares of CRL stock, worth $415,953. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,978
Previous 1,885
4.93%
Holding current value
$415,953
Previous $389,000
0.26%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding CRL
# of Institutions
710Shares Held
51.4MCall Options Held
233KPut Options Held
236K-
Vanguard Group Inc Valley Forge, PA6.1MShares$1.28 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$1.07 Billion0.02% of portfolio
-
State Street Corp Boston, MA2.09MShares$439 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.91MShares$401 Million0.99% of portfolio
-
Allspring Global Investments Holdings, LLC1.76MShares$370 Million0.56% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $10.7B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...